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Looping, Linking, and Chromatin Minireview
Activity: New Insights into
b-globin Locus Regulation
problems arises because many of us evaluate the data
from these two sources as equivalent, even though they
represent a comparison between (randomly integrated
human and murine) transgenes and the natural (murine)
locus. Both mice and humans have similar gene organi-
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zations relative to the LCR (Figure 1) and, thus, if
pressed, most investigators would probably agree that
the loci are likely to be regulated by qualitatively similarAnalysis of globin gene transcription has provided us
mechanisms, since highly sequence-conserved LCRswith one of the most thoroughly studied examples of
regulate the b-globin genes in every organism analyzedtissue- and temporally specific transcriptional control.
to date (Hardison et al., 1998).Many of the concepts and principles of eukaryotic gene
Although there are no specific examples, a secondregulation are a direct consequence of the analysis of
potential pitfall could arise as a consequence of usingglobin loci. Yet, even after decades of molecular analysis
different (cosmid, BAC, or YAC) base DNAs as startingand despite the availability of dozens of naturally oc-
materials in the transgenic studies. Small constructscurring mutations correlated with specific disease phe-
incorporating different parts of the locus are the simplestnotypes, the mechanisms underlying the simple yet ex-
transgenes to construct and analyze, but more recentquisitely reproducible pattern of sequential embryonic,
work has focused on mutations in large linked cosmidsfetal, and adult b-type globin gene transcription remain
and even more recently on very large YACs bearing thesharply controversial and surprisingly elusive. The basic
locus (Figure 1). At present, we have no way of knowingfacts underlying major controversies in this field are
whether all these fragments of DNA (or indeed, if anylargely undisputed, so we refer interested readers to
of them) confer to a transgene an environment equiva-two reviews for a meaningful introduction (Bell and
lent to that encountered by the endogenous genes.Felsenfeld, 1999; Bulger and Groudine, 1999). Two new
A third complication is that various laboratories havepapers examining different aspects of chromatin struc-
(quite naturally) examined different mutations that leadture in the b-globin locus revealed, on the one hand, a
to some of the controversy between independent stud-surprising lack of influence of the locus control region
ies. For example, it was shown using a single YAC that(LCR) on overall chromatin sensitivity, and on the other,
a 2.3 kb deletion encompassing LCR HS3 has far lessa subtlety in the structure of active chromatin that corre-
deleterious consequences on globin gene expressionlates with nonglobin transcription within the locus.
than an analogous deletion of 234 bp defined as theMany of these controversies focus on the in vivo func-
ªcoreº of HS3 (Bungert et al., 1995; Peterson et al., 1996;tion(s) of the LCR, a group of five DNase I hypersensitive
Navas et al., 1998). With this revelation, there shouldsites (HS) located from 6 to about 25 kbp 59 to the
be increased appreciation that any such comparisonsembryonic e-globin gene (Tuan et al., 1985; Forrester et
between ªsimilarº mutations is like comparing applesal., 1986; Figure 1). As but one example of temporal
to oranges.complications that can arise, even our definition of what
Questionsconstitutes the LCR has changed only recently, since it
In spite of experimental and conceptual complicationswas discovered that additional HSs are located even
each approach presents, the central questions in b-glo-
further 59 to the five original HSs (Figure 1). Individual
bin locus gene regulation are fundamental. First, what
globin genes, or even the whole cluster of genes in their
regulatory properties does the LCR actually confer to
natural configuration, are characteristically expressed
b-locus gene regulation, and do these properties func-
at the proper developmental time in transgenic animals tionally effect transcription of the genes? Second, is
but at greatly reduced abundance in comparison to en- differential replication timing through the locus in non-
dogenous globin genes. It was discovered that when erythroid versus erythroid cells a determinant of gene
cis-linked to globin genes, the LCR conferred roughly expression, and if so, how? (Neither of the studies re-
physiological expression levels in transgenic animals viewed here address this specific issue, so it will not be
(Grosveld et al., 1987). These seminal observations sug- further explored). Finally, is the differential chromatin
gested that earlier globin transgenes failed to express structure detected in erythroid versus nonerythroid cells
at high levels simply because they lacked the LCR. a cause or a consequence of globin gene activation,
Experimental Systems and if causal, how does it contribute to differential gene
We are at a stage in the evolution of this field when regulation? It is this final issue that was the focus of
much of our current knowledge and direction is based two recent publications in Molecular Cell (Bender et al.,
on observations made in transgenic mice bearing what 2000; Gribnau et al., 2000).
many investigators believe represents the entire human One of the original properties attributed to the LCR
b-globin gene locus. More recently, studies of germline was a chromatin opening function, a hypothesis consis-
mutants in the endogenous murine locus have provided tent with transgenic data as well as with studies of a
additional insight either in support of or in contrast to natural Hispanic LCR deletion (gdb0-thalassemia; Figure
transgenic investigations. Thus, one level of potential 1). The latter work demonstrated that the globin genes
were not transcribed and that the chromatin surrounding
them was inactive in the Hispanic deletion locus in both*E-mail: d-engel@nwu.edu.
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Figure 1. Proportional Representation of the Human (Upper) and Mouse (Lower) b-globin Loci
Globin genes are represented by blue boxes, putative intergenic transcription start sites by green boxes, and DNase I hypersensitive sites
by numbered yellow spheres. Two lines beneath the human sequences represent the extent of the human genomic locus borne on either a
150 kb YAC or the 70 kb cosmid clones used for transgenic experiments (text). Hypothetical boundary elements (red disks) and endogenous
SfiI restriction enzyme sites are shown on the YAC. Brackets indicate the extent of several (natural or experimental) deletions within the loci.
nonerythroid and erythroid cells, while transfer of the the opposite was true in definitive erythroid cells. Fur-
thermore, intergenic transcription correlated with mod-wild-type locus from nonerythroid to an erythroid envi-
ronment was accompanied by both gene activation and est changes in the regional DNase I chromatin sensitivity
in the locus: an eg ªdomainº was reportedly 2-fold moreincreased DNase I sensitivity (Forrester et al., 1990; Fig-
ure 1). Consequently, it had become virtually axiomatic sensitive than a db domain in primitive erythroid cells,
while the reverse was again true in definitive cells. Fi-that the transcriptional stimulatory component of the
LCR might be difficult to disentangle from its chromatin nally, they reported that an element lying between the
two domains contained a discrete transcription initiationopening activity. The Bender et al. (2000) and Gribnau
et al. (2000) reports highlighted here address qualities of site 59 to the d-globin gene. Deletion of that element
from a transgenic YAC had been shown to diminishdifferential chromatin structure in the locus that demand
reevaluation of these perceptions. b-globin gene transcription in definitive erythroid cells,
and Gribnau et al. (2000) found that this mutation simi-Observations
Bender et al. (2000) presented in vivo evidence that larly inhibited db-domain intergenic transcription. The
important conclusion from this report is that chromatindespite severely diminished transcriptional activity in
the locus after deletion of the LCR (as anticipated from sensitivity of large regions flanking actively transcribed
globin genes may be greater than that of domains that areearlier studies, including their own; Epner et al., 1998),
the mutation had a negligible effect on the general (momentarily) transcriptionally inert and that this DNase
I sensitivity correlates with differences in the abundanceDNase I sensitivity throughout the murine b-globin lo-
cus. This conclusion was congruent with an earlier study of the domain-restricted intergenic transcripts.
Future Questionsin which homologous recombination-mediated deletion
of HS sites 2±5 of the human LCR abolished transcription The Bender and Gribnau papers are of pivotal interest
because they contribute new insights into one of theof the genes without altering general chromatin sensitiv-
ity (Reik et al., 1998; DHS2-5, Figure 1), in stark contrast most basic precepts underlying globin transcriptional
activity. First, Bender et al. (2000) demonstrate that atto studies on the Hispanic deletion (above). The impor-
tant conclusion from these studies is that a second least one chromatin opening activity is separable from
the transcriptional activation function of the b-globindomain of chromatin opening activity must lie outside
the LCR. This second domain must be in addition to LCR. Several questions emerge from this provocative
discovery. Is the LCR alone capable of the same functionthat established by the LCR itself (since the linked cos-
mids used in many transgenic experiments can open (thus identifying this as a redundant property within the
locus), or do HS1-5 cooperatively open chromatinchromatin, but only minimally encompass HS1-5), and
thus deductively a second chromatin opening domain through cis linkage with the genes? Is the new LCR-
independent chromatin opening activity found in themust lie within the 59 most part of the Hispanic deletion
(Figure 1). region described by the difference in the DHS2-5 dele-
tion and the gdb0-thalassemia Hispanic deletion (FigureExtra- and intergenic transcripts within the b-globin
locus have been documented for some time, but a report 1)? What are the molecular identities of the chromatin
modulatory activities that generate independent chro-3 years ago revealed new insights into how pol II±
dependent unidirectional intergenic transcripts might be matin opening?
Gribnau et al. (2000) found that the locus appearsgenerated (Ashe et al., 1997). Now, Gribnau et al. (2000)
describe analysis of the chromatin structure of the trans- to be subdivided into functionally discrete subdomains
that reflect the developmental stage at which the genesgenic human locus, as well as further properties of the
globin intergenic transcripts. Importantly, they found within those domains are transcriptionally active, reveal-
ing a host of new possible levels of regulation. Do thethat the intergenic transcripts surrounding the e- and
g-globin genes were significantly more abundant in intergenic transcripts arise as a cause or a consequence
of chromatin opening or gene transcription? Can otherprimitive erythroid cells (which transcribe only e- and
g-globin) than those from the b-globin gene region, while (than the db domain) nongenic promoters be identified
Minireview
501
Figure 2. Stage-Specific Activation within
Subdomains of the b-globin Locus by an LCR
Holocomplex
Chromatinized DNA status (either relatively
open or closed, which is meant to reflect
general sensitivity to DNase I) is depicted as
spring shapes with the more condensed
chromatin represented as tighter coiling. Indi-
vidual LCR HS sites and genes are shown
as spheres (shaded from yellow to red) and
cylinders (blue), respectively. Purple lines
show possible structural constraints gener-
ated by linkage of two putative boundary elements (purple spheres) and how this might contribute to the formation of chromosomal subdomains.
The architectural constraints within the locus and/or the LCR holocomplex configuration may also influence which gene(s) can be activated
by LCR at specific developmental stages (green arrows representing the domains that are rendered more accessible after differential orientation
of the LCR in the primitive and definitive erythroid stages).
in the locus? Do these intergenic RNAs represent long, are linked to one another by facilitating non-DNA-bind-
ing factors, and these form a continuous protein chainuninterrupted primary transcripts? Is a small deletion,
encompassing only the definitive db domain promoter, from (for example) the LCR to the adult b-globin gene
located 50 kbp away. One can easily envision ways inequally disruptive to adult b-globin transcription as the
2.5 kbp deletion? What is the mechanistic link, if any, which conceptual constraints imposed by this model (for
example, intermediate masking points to preferentiallybetween intergenic and globin gene transcription?
Mechanistic Interpretations transcribe b-globin and bypass g-globin during defini-
tive erythropoiesis) could be incorporated.Both reports highlighted here challenge our perception
of how vertebrate b-globin loci are regulated, although cis Speculation
Given our association with the looping and competitionneither observation is inconsistent with currently popu-
lar models for how the LCR stimulates globin gene tran- models (Choi and Engel, 1988), we can readily incorpo-
rate these new data into predictive corollaries to thescription. Two current models have been abbreviated
ªloopingº or ªlinking,º and the unstated, underlying char- competition hypothesis; however, we note that these
predictions can be applied to support linking as well. Ifacteristics attributed to both are specific and diverse (if
not conflicting). The looping model is predicated on the the human locus is defined by intergenic elements that
promote or restrict the ability of the LCR to activateidea that the LCR acts as an integral unit (a ªholocom-
plexº; Bungert et al., 1995; Wijgerde et al., 1995) to stimu- transcription of genes within subdomains (Figure 2), a
primary layer of chromatin differentiation could serve tolate the transcription of individual globin genes by loop-
ing through nucleoplasm to activate (or recruit) the augment the positive or negative regulatory function
of discrete transcriptional cis elements neighboring thetranscriptional apparatus assembled at globin gene pro-
moters. Since the LCR holocomplex would be limiting genes. For example, we showed that deletion of the
e-globin gene silencer from a YAC has very modest ef-(one activation center), only one gene at a time could
be transcribed, and thus in an equivalent environment fects on e-globin gene expression in adult erythroid cells
(Liu et al., 1997), while the effect of its deletion in trans-the five genes of the human locus would compete for
the activity of the LCR. While there are caveats and genic mice bearing only fragments of the locus is quite
dramatic (Li et al., 1998). We originally proposed thatcorollaries accompanying these basic precepts (e.g.,
to promote differential stage-specific transcription), the functional redundancy of cis elements could account
for the lack of effects detected when the small e-globinbasic looping model cannot be refuted by current clinical
or laboratory observations. gene silencer was deleted from a large transgenic YAC.
The report of Gribnau et al. (2000) support an additionalEven while numerous experiments are consistent with
looping activation of, and competition between, individ- alternative: that discrete cis element mutations are in-
sufficient to confer full expressivity of local ªsilencerºual genes and the LCR, none of them prove fundamental
aspects of the hypothesis. In the absence of definitive or ªenhancerº activities, and that these gene proximal
elements can only act at the proper developmental stageexperimental validation, further consideration of the pro-
fusion of laboratory and clinical observations led to an when they do so within the context of regionally imposed
(metastable) chromatin constraints. Thus, deletion of thealternative model that might have fewer constraints,
could explain the clinical and laboratory observations, e-globin silencer may not confer a significant positive
transcriptional effect on the e-globin gene when exam-and would be consistent with the properties of newly
defined chromatin and/or transcription factor modula- ined in the context of the whole locus because the chro-
matin subdomain harboring e-globin is suppressed intory proteins. Thus evolved the notion of linking.
At its heart, linking is envisioned to be the product of adult erythroid cells (i.e., the primary effect of chromatin
suppression dominates a secondary effect of silencersequential stage-specific binding of transcription fac-
tors and chromatin ªfacilitatorsº throughout the locus deletion).
Clearly there are a host of challenges remaining in(in a topologically unconstrained form) to an array of
chromatin elements that initially define the domain to be this field, not the least of which concerns our ability to
clearly define the caveats and possible limitations intranscribed (Bulger and Groudine, 1999; Dorsett, 1999).
Thus, the proteins bound to a to-be-transcribed locus interpreting each new study within the context of a huge
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body of existing literature. Lest we become complacent,
it's important to remember that each new year for the
past three decades has been accompanied by often
startling revelations about how globin diseases arise,
how the locus is regulated, how LCRs function, and,
most recently, how chromatin structure impinges on
differential modulation of the genes. The formidable
tasks of devising clear distinctions among the possible
models, as well as executing defining experiments to
distinguish among them, is still a challenge we face
daily, and often optimistically.
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